
Sharp Therapeutics Advances Clinical Pipeline Amidst Capital Raise and Lead Compound Optimization
Sharp Therapeutics Announces Closing of Fourth Tranche of Unsecured Convertible Note Offering

Sharp Therapeutics Announces Closing of Fourth Tranche of Unsecured Convertible Note Offering
Betterlife issues 600,000 shares to corporate adviser
Theralase(R) Closes $CAN 2.66 Million Financing
Extendicare Announces $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes
Cheelcare Delivers First Curio Robotic Complex-Rehab Power Wheelchair to Paying Customers and Achieves Record Companion Sales
Sernova Biotherapeutics Announces Affirmative Voting Results from 2026 Annual General Meeting of Shareholders
Netramark-Authored, Peer-Reviewed Article Suggests Psychedelics Might Not Only Affect Brain Chemistry, They May Also Involve Quantum-Level Processes Inside the Brain
JUNO OTC, A WHOLLY-OWNED SUBSIDIARY OF LSL PHARMA GROUP, SIGNS BINDING TERM SHEET WITH INSTAPILL PRIVATE LIMITED TO SUPPLY PRIVATE LABEL LORATADINE 10 MG RDT IN CANADA
Nxera Pharma Achieves Second Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases
Betterlife Pharma arranges $500,000 private placement
Marvel Biosciences Announces Proposed Convertible Debenture Offering
MyndTec Inc. Announces Inability to Secure Financing, Cessation of Operations and Evaluation of Strategic Alternatives Including Insolvency Proceedings
DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA
Rocket Doctor Announces Maryland Expansion and Strategic Appointment of New Medical Lead
Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+(TM) Dual-Port Vitrectomy Cutter and Adaptive Fluidics(TM) Advanced Update